SMi Group is presenting the 5th conference in their highly successful series of Social Media in the Pharmaceutical Industry this January. It will allow companies to focus on how to improve their existing social media strategies, how to innovate into the new and emerging techniques and technologies and enhancing their company’s engagement potential. We are excited to also feature talks from key companies in the industry, including Google, Pfizer, UCB Pharma and Bayer, and will focus on case studies from the industry, techniques for social media use and implementation of social media mechanisms.

Key reasons to attend include:

• Speak with the key opinion leaders of the industry about the future of social media, digital pharma, e-marketing and regulations
• Hear about the case studies in the industry: how the affected those involved, how they were successful and the reasons that they were unsuccessful
• Learn about crisis management, adaptations and risk management in unsuccessful campaigns, and apply them to your own company’s
• Discuss the latest technologies in social media with companies that create them, and debate their benefits and difficulties with those companies that utilise them
• Put forward problems and difficulties of your own, and discuss potential solutions and action plans for the future

Expert Key speakers include:

• Beat Buehlmann, Industry Leader Healthcare UK, Google Inc
• Trish Nettleship, Director, Social Media & Influence, UCB Pharma
• Rahul Agrawal, Global Director, Clinical Development and Strategic
Marketing, Bayer Healthcare
• Andrew Widger, Director, Media Relations EMEA Pfizer Inc
• Josep Picas, President, European Association of Healthcare IT Managers

Book by 28th September and receive a £300 discount